INDRAYANI BIOTECH LTD. (INDRANIB)

BSE: ₹11.29
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Resignation of Mrs. Ramya Ravi as the Company Secretary and Compliance Officer of the Company

2026-06-03 21:07:26
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the year ended 31st March, 2026

2026-05-27 20:36:39
Results-Delay in Financial Results

Delay in financial results for the year ended 31st March, 2026

2026-05-27 20:35:00
Announcement Under Regulation 30

Resignation letter of Mr. Indirakumar

2026-05-27 15:56:17
2026-05-25 19:03:38
General Updates

Outcome of the Rights issue Committee Meeting held on 28-04-2026.

2026-04-28 17:13:31
Announcement Under Regulation 30 (LODR) - IT Demand Notice

Company has received an IT Demand Notice

2026-04-25 20:29:54
Intimation Of ISIN For Rights Entitlements Of Indrayani Biotech Limited

Intimation of ISIN for Rights Entitlement to be credited for the purpose of Rights Issue of Indrayani Biotech Limited

2026-04-21 13:14:39
Corporate Action-Outcome of Right issue

Outcome of the Rights Issue Committee Meeting

2026-04-09 21:32:30
Record Date For The Partly Paid-Up Rights Issue Has Been Fixed As 28Th April, 2026

Record date for the Partly Paid-up Rights Issue has been fixed as 28th April, 2026

2026-04-09 21:31:25

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 16.82 16.01 13.69 15.80 10.79 9.51 8.19 9.28 6.69 12.62 5.20 4.08
YOY Revenue Growth % 7.83% 0.58% -36.77% -25.84% -35.84% -40.63% -40.2% -41.24% -38.04% 32.71% -36.48% -56.05%
Other Income 0.01 0.09 0.08 3.45 1.03 0.89 0.66 0.93 0.89 2.72 0.68 0.82
Total Income 16.82 16.10 13.77 19.25 11.82 10.40 8.85 10.22 7.58 15.33 5.88 4.90
Total Expenses + 16.11 15.69 13.51 17.62 11.65 10.27 8.71 10.01 7.41 14.54 5.77 8.42
Cost of Materials Consumed 9.52 10.29 7.72 7.62 4.85 3.80 3.34 2.80 3.35 6.41 2.04 2.20
Employee Benefit Expense 3.62 3.91 3.27 4.90 4.04 3.20 2.69 3.30 1.50 3.06 1.38 2.58
Other Expenses 1.65 0.52 1.38 2.27 0.93 1.06 0.82 1.46 1.08 2.44 1.12 0.90
Operating Profit 0.71 0.32 0.18 -1.82 -0.86 -0.76 -0.52 -0.73 -0.72 -1.92 -0.57 -4.34
OPM % 4.2% 2% 1.3% -11.5% -7.9% -8% -6.4% -7.9% -10.8% -15.2% -10.9% -106.3%
Profit Before Tax + 0.72 0.41 0.26 1.62 0.17 0.13 0.14 0.20 0.17 0.80 0.11 -3.52
Tax Expense 0.00 0.00 0.00 1.55 0.04 0.03 0.04 0.00 0.04 0.20 0.03 0.08
Tax % 0% 0% 0% 95.5% 25.4% 24.8% 25.2% 0% 25% 25.2% 25.2% -
Profit After Tax 0.72 0.41 0.26 0.07 0.13 0.10 0.11 0.20 0.13 0.60 0.08 -3.59
EPS (Basic) 0.21 0.12 0.06 0.08 0.03 0.02 0.02 0.00 0.03 0.13 0.01 0.01

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 21.90 37.77 62.32 74.48 57.99 21.01 49.90
YOY Revenue Growth % -42.02% -39.4% -16.32% 28.44% 176.04% -57.9% -
Other Income 4.21 3.52 3.62 0.64 0.22 0.26 0.19
Total Income 26.11 41.29 65.94 75.12 58.21 21.27 50.09
Total Expenses + 24.91 40.64 62.93 69.54 53.98 28.05 49.28
Cost of Materials Consumed 10.65 14.78 35.15 41.49 39.71 15.76 31.98
Employee Benefit Expense 7.01 13.24 15.69 17.50 8.97 5.71 11.35
Other Expenses 2.65 4.27 5.81 6.84 3.07 4.21 3.29
Operating Profit -3.01 -2.87 -0.61 4.94 4.00 -7.04 0.62
OPM % -13.7% -7.6% -1% 6.6% 6.9% -33.5% 1.2%
Profit Before Exceptional 1.20 0.65 3.01 5.58 4.23 -6.78 0.81
Exceptional Items 0.00 0.00 0.00 -0.50 0.00 -4.11 0.00
Profit Before Tax + 1.20 0.65 3.01 5.08 4.23 -10.89 0.81
Tax Expense 0.50 -0.80 1.55 0.02 0.00 0.00 0.00
Tax % 41.9% -123.8% 51.6% 0.4% 0% - 0%
Profit After Tax 0.70 1.45 1.46 5.06 4.23 -10.89 0.81
EPS (Basic) 0.15 0.00 0.32 1.48 1.23 -3.18 0.24

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 47.71 50.05 54.50 50.97 29.41 30.34 32.28
Property, Plant & Equipment 12.05 12.83 17.82 19.97 11.49 11.28 13.53
Capital Work in Progress 18.09 18.09 18.03 12.72 13.22 13.72 13.59
Non-Current Investments 0.00 0.00 9.56 7.99 0.19 0.19 0.01
Goodwill 3.84 3.84 3.84 3.84 3.84 3.84 3.84
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 74.22 80.62 71.50 49.33 20.02 9.51 19.20
Inventories 1.76 1.69 1.92 1.86 1.37 1.08 5.07
Trade Receivables 16.10 16.46 17.60 16.23 12.88 4.77 7.04
Cash and Cash Equivalents 0.03 0.06 0.26 0.62 0.04 0.04 0.11
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 56.03 55.33 54.52 51.15 24.18 19.95 30.84
Equity Share Capital 45.54 45.54 45.54 43.48 34.23 34.23 34.23
Other Equity 10.49 9.80 8.98 7.67 -10.05 -14.28 -3.39
Non-Current Liabilities 27.05 13.87 19.97 16.09 6.80 8.17 6.96
Current Liabilities 38.84 61.48 51.52 33.06 18.46 11.73 13.68
Total Liabilities 65.89 75.35 71.49 49.15 25.26 19.90 20.64

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities -14.10 17.35 26.09 8.39 3.48 0.52 5.97
Cash from Investing Activities 1.40 -1.34 -7.22 -14.09 0.59 -0.56 -3.66
Cash from Financing Activities 12.67 -16.22 -19.23 4.87 -3.25 -0.73 -1.30
Net Increase/Decrease in Cash -0.03 -0.20 -0.36 -0.83 0.82 -0.78 1.01